- Home
- IRT vs ADMA Comparison
IRT vs ADMA Comparison
Compare IRT & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRT
- ADMA
- Stock Information
- Founded
- IRT 2009
- ADMA 2004
- Country
- IRT United States
- ADMA United States
- Employees
- IRT N/A
- ADMA N/A
- Industry
- IRT Real Estate Investment Trusts
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IRT Real Estate
- ADMA Health Care
- Exchange
- IRT Nasdaq
- ADMA Nasdaq
- Market Cap
- IRT 4.0B
- ADMA 3.7B
- IPO Year
- IRT 2013
- ADMA N/A
- Fundamental
- Price
- IRT $16.30
- ADMA $14.66
- Analyst Decision
- IRT Buy
- ADMA Strong Buy
- Analyst Count
- IRT 7
- ADMA 3
- Target Price
- IRT $22.14
- ADMA $27.67
- AVG Volume (30 Days)
- IRT 2.7M
- ADMA 3.3M
- Earning Date
- IRT 10-29-2025
- ADMA 11-06-2025
- Dividend Yield
- IRT 4.17%
- ADMA N/A
- EPS Growth
- IRT N/A
- ADMA 469.09
- EPS
- IRT 0.12
- ADMA 0.85
- Revenue
- IRT $645,404,000.00
- ADMA $474,174,000.00
- Revenue This Year
- IRT $4.82
- ADMA $21.08
- Revenue Next Year
- IRT $5.27
- ADMA $25.98
- P/E Ratio
- IRT $135.50
- ADMA $17.35
- Revenue Growth
- IRT N/A
- ADMA 43.58
- 52 Week Low
- IRT $16.12
- ADMA $13.50
- 52 Week High
- IRT $22.26
- ADMA $25.67
- Technical
- Relative Strength Index (RSI)
- IRT 34.10
- ADMA 36.06
- Support Level
- IRT $16.12
- ADMA $14.43
- Resistance Level
- IRT $16.45
- ADMA $15.38
- Average True Range (ATR)
- IRT 0.29
- ADMA 0.52
- MACD
- IRT -0.07
- ADMA -0.07
- Stochastic Oscillator
- IRT 14.96
- ADMA 10.69
About IRT Independence Realty Trust Inc.
Independence Realty Trust Inc is a real estate investment trust (REIT) that acquires, owns, operates, improves and manages multifamily apartment communities across non-gateway U.S. markets. It owns and operates multifamily apartment properties, across non-gateway U.S markets, including Louisville, Memphis, Atlanta, and Raleigh. The company is focused on gaining scale within key amenity-rich submarkets that offer school districts, retail, and various employment centers.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.